Nanjing Vazyme Biotech. (688105.SHG) Q2 2024 Earnings

27AprConfirmed
Q3 2022
Q1 2023
Q2 2023
Q2 2024
-0.38
-0.14
0.1
0.34

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Nanjing Vazyme Biotech. (688105.SHG) will report earnings of for Q2 2024 on April 27, 2024.

0 Comments

Share your thoughts